Literature DB >> 28840502

Case report: Coxiella burnetii vascular infection and lymphoma in the Netherlands.

Sonja E van Roeden1, Cléa Melenotte2, Mirjam H A Hermans3, Harm A M Sinnige4, Peet T G A Nooijen5, Gilles Audoly2, Andy I M Hoepelman6, Jan Jelrik Oosterheert6, Didier Raoult2, Peter C Wever3.   

Abstract

OBJECTIVES AND
DESIGN: Non-Hodgkin lymphoma has been linked to infection with Coxiella burnetii, potentially through overproduction of IL-10 during infection with C. burnetii.
MATERIALS AND METHODS: Description of a case report.
RESULTS: We describe a patient with retroperitoneal non-Hodgkin lymphoma and vascular infection with C. burnetii. Immunofluorescence staining and fluorescence in situ hybridization targeting specific C. burnetii 16S rRNA were performed on the retroperitoneal lymphoma tissue sample obtained at diagnosis of NHL. Both were strongly positive for the presence of C. burnetii.
CONCLUSIONS: This case provokes questions regarding a potential association between C. burnetii and NHL, and underlines the importance of further exploration of this association.

Entities:  

Keywords:  Coxiella burnetii; Non-Hodgkin lymphoma; Q fever

Mesh:

Substances:

Year:  2017        PMID: 28840502      PMCID: PMC5790848          DOI: 10.1007/s15010-017-1061-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


Case report

A 58-year-old male patient, with a history of a vascular bypass because of occlusion of the infrarenal aorta in September 2010 and rheumatoid arthritis for which he used etanercept weekly, underwent abdominal ultrasound during routine follow-up in September 2012. He mentioned lower abdominal pain since a few weeks, but did not report any night sweats, fever, weight loss, rash or other complaints. He did not have any contact with animals, but lived in the Netherlands in an area where Q fever had been highly epidemic between 2007 and 2010 [1]. Laboratory results on presentation are shown in Table 1. On abdominal ultrasound, bilateral hydronephrosis with extensive retroperitoneal masses was observed. A subsequent computed tomography scan and positron emission tomography (PET) scan showed extensive retroperitoneal, intra-abdominal, mediastinal, cervical, and axillary lymphadenopathy, a pulmonary mass and a lesion in the right adrenal. In addition, the abdominal aorta and left iliac artery showed increased 18F-FDG uptake, which was not further analyzed. The PET-scan was made as part of the standard work-up procedure of suspected NHL, in accordance with Dutch guidelines [2, 3]. Biopsy of the retroperitoneal masses and a bone marrow biopsy revealed an Ann Arbor stage IV B cell non-Hodgkin lymphoma (NHL), with initially indefinite histopathological classification of the subtype of NHL. Re-examination of the pathology specimens at an academic hospital confirmed the presence of a B-cell NHL, with a marginal zone lymphoma as the most likely histopathological subtype. Chemo-immunotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) was initiated and etanercept was discontinued. After discontinuation of etanercept, the patient experienced two flares of his rheumatoid arthritis for which he received short courses of prednisone. Follow-up PET scan after three cycles of chemotherapy showed regression of all lymphoma locations, with the exception of pulmonary lesion, adrenal mass, and lower cervical lymph nodes. The increased 18F-FDG uptake in aorta and left iliac artery was unchanged. Because of unresponsiveness to chemotherapy of the pulmonary lesion, a second malignancy, possibly metastatic lung carcinoma, was suspected and further analysis was planned. Meanwhile, chemotherapy was discontinued, while awaiting analysis of the suspected lung lesion. Shortly after the last PET scan, the patient was diagnosed with pulmonary embolism for which heparin was started. Because of the use of anticoagulants and difficult accessibility of the pulmonary lesion, the diagnosis could not be confirmed pathologically. A follow-up PET scan was performed in February 2013, on which all NHL localizations were persistently in regression. However, the 18F-FDG uptake in the aorta and left iliac artery had strongly increased and the pulmonary lesion and pathological cervical lymph nodes were unchanged. The adrenal lesion was slightly larger. Patient was referred for second opinion and after due consideration did not want any further diagnostics and treatment of his pulmonary lesion. Analysis of the increased uptake in the aorta and left iliac artery was performed in June 2013. Repeated PET scanning revealed highly increased uptake of 18F-FDG of the abdominal aorta and left iliac artery, and a lesion suspicious of a small abscess near the left iliac artery (Fig. 1). As infection of the vascular bypass was suspected, blood cultures and serology for Coxiella burnetii were performed. Blood cultures were negative, but phase I and II IgG antibodies for C. burnetii were repeatedly positive with a maximum phase I IgG antibody titer of 1:4096 (Indirect Fluorescent-antibody Assay, Focus Diagnostics, Inc., Cypress, CA, USA). Phase I and II IgM antibodies against C. burnetii were negative. Polymerase chain reaction on serum was performed twice, but both samples tested negative. Vascular infection with C. burnetii was diagnosed according to both the Dutch chronic Q fever consensus group criteria and the criteria formulated by Eldin et al., and treatment with doxycycline (200 mg once daily) and hydroxychloroquine (200 mg three times daily) was started in July 2013 [4, 5]. No signs of endocarditis were present on physical examination or PET-CT, but an echocardiogram was not performed. In the absence of an echocardiogram, the presence of concomitant endocarditis could not be excluded with certainty [4, 6]. After start of the treatment, the patient experienced severe gastro-intestinal side effects and refused further therapy in September 2013. In March 2014, he reported repeated melena and rectal bleeding. An aortoduodenal fistula was suspected, but the patient did not want any further diagnostic interventions. His clinical condition deteriorated and he died the same month.
Table 1

Laboratory results at the day of presentation

Laboratory measurementResultNormal rangeUnits of measurement
Hemoglobin7.28.5–11.0mmol/L
Thrombocytes179150–400109/L
Leukocytesa 9.24.0–10.0109/L
Creatininea 55160–110µmol/L
C-reactive protein140–8mg/L
Aspartate aminotransferasea 190–34U/L
Alanine aminotransferasea 130–44U/L
Gamma-glutamyltransferasea <100–54U/L
Alkaline phosphatasea 8143–115U/L
Lactate dehydrogenasea 2460–247U/L

aIn the days following initial presentation, these laboratory values changed. Maximum values during admission were: leukocyte count 35.6 × 109/L, C-reactive protein 186 mg/L, aspartate aminotransferase 35, alanine aminotransferase 49, alkaline phosphatase 177, gamma-glutamyltransferase 146, lactate dehydrogenase 400

Fig. 1

Composite figure of PET-CT, immunofluorescence (IF) and fluorescence in situ hybridization (FISH). a Highly increased 18F-FDG uptake in the aortic wall. b Highly increased 18F-FDG uptake in the left iliac artery. c Microscopic image (original magnification ×100) of immunofluorescence staining (IF) of retroperitoneal lymphoma tissue of a patient with vascular chronic Q fever in which nuclei are stained blue (4′,6-diamidino-2-phenylindole, DAPI), while perinuclear Coxiella burnetii is stained red. d Microscopic image (original magnification ×100) of fluorescence in situ hybridization (FISH) of the same tissue in which nuclei are stained blue (4′,6-diamidino-2-phenylindole, DAPI), while C. burnetii, organized in perinuclear vacuoles, is stained yellow. Yellow signal results of the co-localization of the universal probe EUB (red) and specific 16S rRNA C. burnetii probe (green). For both c, d Leica DMI6000 B microscope was used

Laboratory results at the day of presentation aIn the days following initial presentation, these laboratory values changed. Maximum values during admission were: leukocyte count 35.6 × 109/L, C-reactive protein 186 mg/L, aspartate aminotransferase 35, alanine aminotransferase 49, alkaline phosphatase 177, gamma-glutamyltransferase 146, lactate dehydrogenase 400 Composite figure of PET-CT, immunofluorescence (IF) and fluorescence in situ hybridization (FISH). a Highly increased 18F-FDG uptake in the aortic wall. b Highly increased 18F-FDG uptake in the left iliac artery. c Microscopic image (original magnification ×100) of immunofluorescence staining (IF) of retroperitoneal lymphoma tissue of a patient with vascular chronic Q fever in which nuclei are stained blue (4′,6-diamidino-2-phenylindole, DAPI), while perinuclear Coxiella burnetii is stained red. d Microscopic image (original magnification ×100) of fluorescence in situ hybridization (FISH) of the same tissue in which nuclei are stained blue (4′,6-diamidino-2-phenylindole, DAPI), while C. burnetii, organized in perinuclear vacuoles, is stained yellow. Yellow signal results of the co-localization of the universal probe EUB (red) and specific 16S rRNA C. burnetii probe (green). For both c, d Leica DMI6000 B microscope was used We performed immunofluorescence staining (IF) and fluorescence in situ hybridization (FISH) targeting specific C. burnetii 16S rRNA on the retroperitoneal lymphoma tissue sample obtained at diagnosis of NHL in 2012, which were both strongly positive, Fig. 1. We refer to a previous article for technical details on IF and FISH for C. burnetii [7]. FISH is a relatively novel diagnostic method for detection of C. burnetii, with few studies using FISH targeting C. burnetii performed. The technique was applied in one clinical study and one case-report only [7, 8]. Melenotte et al. were able to detect C. burnetii in four out of seven lymphoma biopsies with FISH. All samples had positive immunofluorescence as confirmation, but negative immunohistochemistry [7]. Both FISH and IF are highly sensitive new diagnostic techniques to detect bacteria in situ, that may be superior to immunohistochemistry. The presence of C. burnetii in the NHL tissue indicates that the infection was already present at the time of diagnosis of NHL in September 2012. At the moment of presentation in September 2012, our patient did not report any weight loss or fever. Nevertheless, he developed clear signs of inflammation shortly after admission (see Table 1). A potential explanation for the absence of fever at presentation may be the fact that our patient was immunocompromised. Absence of weight loss may be due to the fact that self-reporting of symptoms is not very accurate. In the Dutch national chronic Q fever database with data of 439 patients with persistent or chronic Q fever from the Netherlands, only 14% of patients had fever and only 28% of patients reported weight loss at presentation [9]. The absence of these symptoms illustrates that patients with a chronic infection can present with atypical symptoms. It has been hypothesized that there is a causal relationship between persistent infection with C. burnetii and development of B-cell NHL [7]. Our patient presents similar as the index case of the series reporting a link between Q fever and B cell lymphoma: both patients had a vascular focus of infection and lymphoma located closely to the focus of infection [7]. A potential pathophysiological pathway is overproduction of IL-10 during infection with C. burnetii, which could play a role in the development of B-cell NHL [7, 10]. However, both diseases have a considerable diagnostic delay. It cannot be ruled out that C. burnetii infects monocytes and macrophages in tumorous tissue and that this patient had developed NHL before infection. Furthermore, both diseases have common risk factors, such as immunocompromised state [11, 12]. Our patient was severely immunocompromised, which is a risk factor for development of both the lymphoma and the vascular infection with C. burnetii. In this report, we describe a case of NHL after Q fever. Naturally, no hard conclusions with regard to the association between C. burnetii and NHL and its causality can be drawn based on one single case. However, this case provokes further questions regarding the potential association between C. burnetii infection and NHL and its causality and potential diagnostic tools for detection of C. burnetii in tissues.
  9 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming.

Authors:  Frederika Dijkstra; Wim van der Hoek; Nancy Wijers; Barbara Schimmer; Ariene Rietveld; Clementine J Wijkmans; Piet Vellema; Peter M Schneeberger
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02

Review 3.  Host factors in the severity of Q fever.

Authors:  D Raoult
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Rapid molecular diagnosis of infective aortic valve endocarditis caused by Coxiella burnetii.

Authors:  Oliver Kumpf; Pascal Dohmen; Martin Ertmer; Fabian Knebel; Alexandra Wiessner; Judith Kikhney; Annette Moter; Sascha Treskatsch
Journal:  Infection       Date:  2016-06-23       Impact factor: 3.553

Review 5.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  B-cell non-Hodgkin lymphoma linked to Coxiella burnetii.

Authors:  Cléa Melenotte; Matthieu Million; Gilles Audoly; Audrey Gorse; Hervé Dutronc; Gauthier Roland; Michal Dekel; Asuncion Moreno; Serge Cammilleri; Maria Patrizia Carrieri; Camelia Protopopescu; Philippe Ruminy; Hubert Lepidi; Bertrand Nadel; Jean-Louis Mege; Luc Xerri; Didier Raoult
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

Review 7.  Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

Authors:  M C A Wegdam-Blans; L M Kampschreur; C E Delsing; C P Bleeker-Rovers; T Sprong; M E E van Kasteren; D W Notermans; N H M Renders; H A Bijlmer; P J Lestrade; M P G Koopmans; M H Nabuurs-Franssen; J J Oosterheert
Journal:  J Infect       Date:  2011-12-23       Impact factor: 6.072

Review 8.  Non-Hodgkin lymphoma.

Authors:  Kate R Shankland; James O Armitage; Barry W Hancock
Journal:  Lancet       Date:  2012-07-25       Impact factor: 79.321

9.  Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

Authors:  Y Levy; J C Brouet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

  9 in total
  2 in total

1.  A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever.

Authors:  Cléa Melenotte; Soraya Mezouar; Amira Ben Amara; Simon Benatti; Jacques Chiaroni; Christian Devaux; Régis Costello; Guido Kroemer; Jean-Louis Mege; Didier Raoult
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

2.  No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007-2010 Q fever outbreak.

Authors:  Jesper M Weehuizen; Sonja E van Roeden; Sander J Hogewoning; Wim van der Hoek; Marc J M Bonten; Andy I M Hoepelman; Chantal P Bleeker-Rovers; Peter C Wever; Jan Jelrik Oosterheert
Journal:  Int J Epidemiol       Date:  2022-10-13       Impact factor: 9.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.